Production (Stage)
Tectonic Therapeutic, Inc.
TECX
$21.65
-$0.55-2.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 141.70% | 119.89% | 87.63% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.02% | 29.94% | 17.05% | -- | -- |
| Operating Income | -47.02% | -29.94% | -17.05% | -- | -- |
| Income Before Tax | -34.56% | -35.40% | -18.19% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.56% | -35.40% | -18.19% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.56% | -35.40% | -18.19% | -- | -- |
| EBIT | -47.02% | -29.94% | -17.05% | -- | -- |
| EBITDA | -48.38% | -30.58% | -17.41% | -- | -- |
| EPS Basic | 77.85% | 39.15% | 16.11% | -- | -- |
| Normalized Basic EPS | 77.85% | 39.15% | 16.11% | -- | -- |
| EPS Diluted | 77.85% | 39.15% | 16.11% | -- | -- |
| Normalized Diluted EPS | 77.85% | 39.15% | 16.11% | -- | -- |
| Average Basic Shares Outstanding | 840.80% | 453.89% | 179.22% | -- | -- |
| Average Diluted Shares Outstanding | 840.80% | 453.89% | 179.22% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |